This report provides a complete quantitative data and qualitative analysis on the global market for Topical Pain Management Therapeutics. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Topical Pain Management Therapeutics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Topical Pain Management Therapeutics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Topical Pain Management Therapeutics, including the following market information:
Global Topical Pain Management Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Topical Pain Management Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Topical Pain Management Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Topical Pain Management Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Pfizer, GlaxoSmithKline, Endo Pharmaceuticals, Johnson & Johnson Services, Hisamitsu Pharmaceutical, Teva Pharmaceutical Industries, Beiersdorf, Mayne Pharma Group Limited, Sanofi, Topical BioMedics, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Anesthetics
Analgesics
Skeletal Muscle Relaxants
Based on the Application:
Hospital Pharmacies
Drug Stores
Online pharmacies
Prior to COVID-19, the global market for Topical Pain Management Therapeutics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Topical Pain Management Therapeutics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Topical Pain Management Therapeutics, including the following market information:
Global Topical Pain Management Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Topical Pain Management Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Topical Pain Management Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Topical Pain Management Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Pfizer, GlaxoSmithKline, Endo Pharmaceuticals, Johnson & Johnson Services, Hisamitsu Pharmaceutical, Teva Pharmaceutical Industries, Beiersdorf, Mayne Pharma Group Limited, Sanofi, Topical BioMedics, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Anesthetics
Analgesics
Skeletal Muscle Relaxants
Based on the Application:
Hospital Pharmacies
Drug Stores
Online pharmacies
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Topical Pain Management Therapeutics Industry
1.7 COVID-19 Impact: Topical Pain Management Therapeutics Market Trends
2 Global Topical Pain Management Therapeutics Quarterly Market Size Analysis
2.1 Topical Pain Management Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Topical Pain Management Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Topical Pain Management Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Topical Pain Management Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Topical Pain Management Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Topical Pain Management Therapeutics Market
3.4 Key Players Topical Pain Management Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Topical Pain Management Therapeutics Segments, By Type
4.1 Introduction
1.4.1 Anesthetics
1.4.2 Analgesics
1.4.3 Skeletal Muscle Relaxants
4.2 By Type, Global Topical Pain Management Therapeutics Market Size, 2019-2021
5 Impact of Covid-19 on Topical Pain Management Therapeutics Segments, By Application
5.1 Overview
5.5.1 Hospital Pharmacies
5.5.2 Drug Stores
5.5.3 Online pharmacies
5.2 By Application, Global Topical Pain Management Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Topical Pain Management Therapeutics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.1.3 Pfizer Topical Pain Management Therapeutics Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Business Overview
7.2.2 GlaxoSmithKline Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.2.3 GlaxoSmithKline Topical Pain Management Therapeutics Product Introduction
7.2.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.3 Endo Pharmaceuticals
7.3.1 Endo Pharmaceuticals Business Overview
7.3.2 Endo Pharmaceuticals Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.3.3 Endo Pharmaceuticals Topical Pain Management Therapeutics Product Introduction
7.3.4 Endo Pharmaceuticals Response to COVID-19 and Related Developments
7.4 Johnson & Johnson Services
7.4.1 Johnson & Johnson Services Business Overview
7.4.2 Johnson & Johnson Services Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.4.3 Johnson & Johnson Services Topical Pain Management Therapeutics Product Introduction
7.4.4 Johnson & Johnson Services Response to COVID-19 and Related Developments
7.5 Hisamitsu Pharmaceutical
7.5.1 Hisamitsu Pharmaceutical Business Overview
7.5.2 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.5.3 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics Product Introduction
7.5.4 Hisamitsu Pharmaceutical Response to COVID-19 and Related Developments
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Business Overview
7.6.2 Teva Pharmaceutical Industries Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.6.3 Teva Pharmaceutical Industries Topical Pain Management Therapeutics Product Introduction
7.6.4 Teva Pharmaceutical Industries Response to COVID-19 and Related Developments
7.7 Beiersdorf
7.7.1 Beiersdorf Business Overview
7.7.2 Beiersdorf Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.7.3 Beiersdorf Topical Pain Management Therapeutics Product Introduction
7.7.4 Beiersdorf Response to COVID-19 and Related Developments
7.8 Mayne Pharma Group Limited
7.8.1 Mayne Pharma Group Limited Business Overview
7.8.2 Mayne Pharma Group Limited Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.8.3 Mayne Pharma Group Limited Topical Pain Management Therapeutics Product Introduction
7.8.4 Mayne Pharma Group Limited Response to COVID-19 and Related Developments
7.9 Sanofi
7.9.1 Sanofi Business Overview
7.9.2 Sanofi Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.9.3 Sanofi Topical Pain Management Therapeutics Product Introduction
7.9.4 Sanofi Response to COVID-19 and Related Developments
7.10 Topical BioMedics
7.10.1 Topical BioMedics Business Overview
7.10.2 Topical BioMedics Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.10.3 Topical BioMedics Topical Pain Management Therapeutics Product Introduction
7.10.4 Topical BioMedics Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Topical Pain Management Therapeutics Industry
1.7 COVID-19 Impact: Topical Pain Management Therapeutics Market Trends
2 Global Topical Pain Management Therapeutics Quarterly Market Size Analysis
2.1 Topical Pain Management Therapeutics Business Impact Assessment - COVID-19
2.1.1 Global Topical Pain Management Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Topical Pain Management Therapeutics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Topical Pain Management Therapeutics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Topical Pain Management Therapeutics Headquarters and Area Served
3.3 Date of Key Players Enter into Topical Pain Management Therapeutics Market
3.4 Key Players Topical Pain Management Therapeutics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Topical Pain Management Therapeutics Segments, By Type
4.1 Introduction
1.4.1 Anesthetics
1.4.2 Analgesics
1.4.3 Skeletal Muscle Relaxants
4.2 By Type, Global Topical Pain Management Therapeutics Market Size, 2019-2021
5 Impact of Covid-19 on Topical Pain Management Therapeutics Segments, By Application
5.1 Overview
5.5.1 Hospital Pharmacies
5.5.2 Drug Stores
5.5.3 Online pharmacies
5.2 By Application, Global Topical Pain Management Therapeutics Market Size, 2019-2021
5.2.1 By Application, Global Topical Pain Management Therapeutics Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.1.3 Pfizer Topical Pain Management Therapeutics Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Business Overview
7.2.2 GlaxoSmithKline Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.2.3 GlaxoSmithKline Topical Pain Management Therapeutics Product Introduction
7.2.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.3 Endo Pharmaceuticals
7.3.1 Endo Pharmaceuticals Business Overview
7.3.2 Endo Pharmaceuticals Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.3.3 Endo Pharmaceuticals Topical Pain Management Therapeutics Product Introduction
7.3.4 Endo Pharmaceuticals Response to COVID-19 and Related Developments
7.4 Johnson & Johnson Services
7.4.1 Johnson & Johnson Services Business Overview
7.4.2 Johnson & Johnson Services Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.4.3 Johnson & Johnson Services Topical Pain Management Therapeutics Product Introduction
7.4.4 Johnson & Johnson Services Response to COVID-19 and Related Developments
7.5 Hisamitsu Pharmaceutical
7.5.1 Hisamitsu Pharmaceutical Business Overview
7.5.2 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.5.3 Hisamitsu Pharmaceutical Topical Pain Management Therapeutics Product Introduction
7.5.4 Hisamitsu Pharmaceutical Response to COVID-19 and Related Developments
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Business Overview
7.6.2 Teva Pharmaceutical Industries Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.6.3 Teva Pharmaceutical Industries Topical Pain Management Therapeutics Product Introduction
7.6.4 Teva Pharmaceutical Industries Response to COVID-19 and Related Developments
7.7 Beiersdorf
7.7.1 Beiersdorf Business Overview
7.7.2 Beiersdorf Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.7.3 Beiersdorf Topical Pain Management Therapeutics Product Introduction
7.7.4 Beiersdorf Response to COVID-19 and Related Developments
7.8 Mayne Pharma Group Limited
7.8.1 Mayne Pharma Group Limited Business Overview
7.8.2 Mayne Pharma Group Limited Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.8.3 Mayne Pharma Group Limited Topical Pain Management Therapeutics Product Introduction
7.8.4 Mayne Pharma Group Limited Response to COVID-19 and Related Developments
7.9 Sanofi
7.9.1 Sanofi Business Overview
7.9.2 Sanofi Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.9.3 Sanofi Topical Pain Management Therapeutics Product Introduction
7.9.4 Sanofi Response to COVID-19 and Related Developments
7.10 Topical BioMedics
7.10.1 Topical BioMedics Business Overview
7.10.2 Topical BioMedics Topical Pain Management Therapeutics Quarterly Revenue, 2020
7.10.3 Topical BioMedics Topical Pain Management Therapeutics Product Introduction
7.10.4 Topical BioMedics Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
